In prostate cancer, bradykinin has been shown to enhance migration and spread by augmenting ICAM-1 expression, and micrometastasis could be inhibited by blocking integrin αVβ3 and ICAM-1. The gene discussed is ICAM1; the disease is prostate carcinoma.